<DOC>
	<DOCNO>NCT02775448</DOCNO>
	<brief_summary>Metabolic disorder include hypercholesterolemia hypertriglyceridemia present climacteric woman . Carduus marianus homeopathic medicine traditionally use hepatic disease . It use reduce hypercholesterolemia hypertriglyceridemia also . The aim study investigate effective dose Carduus marianus centesimal scale ( 6cH , 12cH , 30cH , placebo ) plus diet exercise reduce hypertriglyceridemia and/or hypercholesterolemia climacteric woman .</brief_summary>
	<brief_title>Dose-response Study Carduus Marianus Centesimal Scale Dyslipidemia Climacteric Overweighed Obese Women .</brief_title>
	<detailed_description>The prevalence metabolic disorder include dyslipidemia increase woman transition premenopause postmenopause . This increase risk morbidity mortality cardiovascular disease . Carduus marianus homeopathic medicine traditionally use hepatic disease . Silymarin , isolate Carduus marianus , owe therapeutic hepatoprotective effect strong antioxidant anti-inflammatory property . Carduus marianus frequently use clinical practice reduces plasma level triglyceride , total cholesterol LDL humans dyslipidemia . Not homeopaths agree dosage potency prescribe homeopathic medicine . The aim study ass : ( 1 ) effective dose Carduus marianus centesimal scale reduce hypertriglyceridemia and/or hypercholesterolemia climacteric woman ; ( 2 ) effect Carduus marianus metabolic parameter ( glucose , glycosylated hemoglobin , insulin resistance , weight , body mass index , waist circumference ) . This 8-week , double-blind , randomize , parallel , four-group , dose-response study ass safety efficacy Carduus marianus 6cH , 12cH , 30cH placebo plus diet exercise , reduce hypertriglyceridemia and/or hypercholesterolemia climacteric woman .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1. woman 4065 year early late transition menopause postmenopause accord STRAW classification 2. hypertriglyceridemia [ &gt; 150 &lt; 1000 mg/dL ] , and/or hypercholesterolemia [ &gt; 200mg/dL ] 3. overweight obesity [ BMI &gt; 25 Kg/m2 ] 4. fast glucose &lt; 126mg/dL 5. glycosylated hemoglobin &lt; 6.5 % 6. willing capable follow study procedure . 1. history cardiovascular disease coronary risk equivalent 2. secondary hyperlipidemia cause diabetes mellitus , renal , liver thyroid diseases 3. hypolipidemic agent , antidiabetic medication , hormone replacement therapy , tamoxifen , raloxifene , danazol , isotretinoin , acitretin , cyclosporin , azathioprine , protease inhibitor ( amprenavir , indinavir , nelfinavir , ritonavir , saquinavir ) , antipsychotic ( clozapine ) , seizure medication ( carbamazepine , valproic acid , phenobarbital , phenytoin ) either ongoing time previous 2 month 4. clinically significant illness , opinion investigator , might put patient risk harm study might adversely affect interpretation study data 5. pregnancy breastfeeding .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Homeopathy</keyword>
	<keyword>Carduus marianus</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Climacteric</keyword>
	<keyword>Obesity</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>LDL-cholesterol</keyword>
	<keyword>HDL-cholesterol</keyword>
</DOC>